Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion

Cancer Research

Volumn 62, Issue 24, 2002, Pages 7139-7142

  Nylandsted, Jesper ^a   Wick, Wolfgang ^b   Hirt, Ulrich A ^c   Brand, Karsten ^d   Rohde, Mikkel ^a   Leist, Marcel ^e   Weller, Michael ^b   Jäättelä, Marja ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; COMPLEMENTARY DNA; HEAT SHOCK PROTEIN 70;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL DEATH; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ERADICATION THERAPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PHAGOCYTOSIS; PRIORITY JOURNAL; TUMOR CELL LINE; VIRAL GENE THERAPY; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; BREAST NEOPLASMS; COLONIC NEOPLASMS; DNA, ANTISENSE; FEMALE; GLIOBLASTOMA; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, SCID; PHAGOCYTOSIS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037115547     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jäättelä, M. Heat shock proteins as cellular lifeguards, Ann. Med., 31: 261-271, 1999.
2. Hermisson, M., Strik, H., Rieger, J., Dichgans, J., Meyermann, R., and Weller, M. Expression and functional activity of heat shock proteins in human glioblastoma multiforme. Neurology, 54: 1357-1365, 2000.
3. Xanthoudakis, S., and Nicholson, D. W. Heat-shock proteins as death determinants. Nat. Cell Biol., 2: E163-E165, 2000.
4. Jäättelä, M. Overexpression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells. Int. J. Cancer, 60: 689-693, 1995.
5. Seo, J. S., Park, Y. M., Kim, J. I., Shim, E. H., Kim, C. W., Jang, J. J., Kim, S. H., and Lee, W. H. T cell lymphoma in transgenic mice expressing the human hsp70 gene. Biochem. Biophys. Res. Comm., 218: 582-587, 1996.
6. Volloch, V. Z., and Sherman, M. Y. Oncogenic potential of Hsp72. Oncogene, 18: 3648-3651, 1999.
7. Gurbuxani, S., Bruey, J. M., Fromentin, A., Larmonier, N., Parcellier, A., Jäättelä, M., Martin, F., Solary, E., and Garrido, C. Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene, 20: 7478-7485, 2001.
8. Wei, Y., Zhao, X., Kariya, Y., Teshigawara, K., and Uchida, A. Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) expression in tumor cells. Cancer Immunol. Immunother., 40: 73-78, 1995.
9. Nylandsted, J., Rohde, M., Brand, K., Bastholm, L., Elling, F., and Jäättelä, M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc. Natl. Acad. Sci. USA, 97: 7871-7876, 2000.
10. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
11. Leist, M., and Jäättelä, M. Four deaths and a funeral: From caspases to alternative mechanisms. Nat. Rev. Mol. Cell. Biol., 2: 589-598, 2001.
12. Mathiasen, I. S., and Jäättelä, M. Triggering caspase-independent cell death to combat cancer. Trends Mol. Med., 8: 212-220, 2002.
13. Jäättelä, M., Wissing, D., Kokholm, K., Kallunki, T., and Egeblad, M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J., 17: 6124-6134, 1998.
14. Hirt, U. A., Gantner, F., and Leist, M. Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J. Immunol., 164: 6520-6529, 2000.
15. Wick, W., Grimmel, C., Wild-Bode, C., Platten, M., Arpin, M., and Weller, M. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-β2. J. Neurosci., 21: 3360-3368, 2001.
16. Reiter, I., Krammer, B., and Schwamberger, G. Cutting edge: Differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J. Immunol., 163: 1730-1732, 1999.
17. Mathiasen, I. S., Lademann, U., and Jäättelä, M. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res., 59: 4848-4856, 1999.